Simplex Trading’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.5K | Buy |
+25,100
| New | +$62.3K | ﹤0.01% | 5791 |
|
|
2025
Q4 | – | Sell |
-16,400
| Closed | -$36K | – | 9731 |
|
|
2025
Q3 | $36K | Sell |
16,400
-72,000
| -81% | -$117K | ﹤0.01% | 6781 |
|
|
2025
Q2 | $130K | Sell |
88,400
-10,500
| -11% | -$21.5K | ﹤0.01% | 4972 |
|
|
2025
Q1 | $253K | Buy |
98,900
+89,700
| +975% | +$214K | ﹤0.01% | 4082 |
|
|
2024
Q4 | $17K | Buy |
+9,200
| New | +$13K | ﹤0.01% | 6821 |
|
|
2024
Q3 | – | Sell |
-1,200
| Closed | -$1K | – | 9325 |
|
|
2024
Q2 | $1K | Sell |
1,200
-2,600
| -68% | -$3.07K | ﹤0.01% | 8526 |
|
|
2024
Q1 | $4K | Sell |
3,800
-76,400
| -95% | -$114K | ﹤0.01% | 8149 |
|
|
2023
Q4 | $142K | Buy |
80,200
+15,200
| +23% | +$23.6K | ﹤0.01% | 5027 |
|
|
2023
Q3 | $107K | Buy |
65,000
+44,600
| +219% | +$80.1K | ﹤0.01% | 5019 |
|
|
2023
Q2 | $40K | Sell |
20,400
-449,100
| -96% | -$1.07M | ﹤0.01% | 6061 |
|
|
2023
Q1 | $985K | Buy |
469,500
+133,800
| +40% | +$235K | ﹤0.01% | 2599 |
|
|
2022
Q4 | $459K | Buy |
335,700
+102,600
| +44% | +$113K | ﹤0.01% | 3241 |
|
|
2022
Q3 | $242K | Sell |
233,100
-129,100
| -36% | -$143K | ﹤0.01% | 4373 |
|
|
2022
Q2 | $394K | Buy |
362,200
+126,400
| +54% | +$148K | ﹤0.01% | 3748 |
|
|
2022
Q1 | $249K | Buy |
235,800
+171,600
| +267% | +$157K | ﹤0.01% | 4819 |
|
|
2021
Q4 | $53K | Sell |
64,200
-226,600
| -78% | -$237K | ﹤0.01% | 7195 |
|
|
2021
Q3 | $543K | Sell |
290,800
-300
| -0.1% | -$456 | ﹤0.01% | 3969 |
|
|
2021
Q2 | $556K | Buy |
291,100
+291,048
| +559,708% | +$1M | ﹤0.01% | 3984 |
|
|
2021
Q1 | $23K | Sell |
52
-347
| -87% | -$1.62K | ﹤0.01% | 7349 |
|
|
2020
Q4 | $144K | Buy |
399
+394
| +7,880% | +$1.41K | ﹤0.01% | 5036 |
|
|
2020
Q3 | $1K | Sell |
5
-184
| -97% | -$665 | ﹤0.01% | 7583 |
|
|
2020
Q2 | $71K | Buy |
189
+161
| +575% | +$550 | ﹤0.01% | 5158 |
|
|
2020
Q1 | $6K | Sell |
28
-1
| -3% | -$3 | ﹤0.01% | 6762 |
|
|
2019
Q4 | $9K | Buy |
+29
| New | +$71 | ﹤0.01% | 6444 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | -$1K | – | 7905 |
|
|
2018
Q2 | $1K | Buy |
+3
| New | +$13 | ﹤0.01% | 7184 |
|
|
2016
Q3 | – | Sell |
-15
| Closed | -$1K | – | 6318 |
|
|
2016
Q2 | $1K | Buy |
+15
| New | +$120 | ﹤0.01% | 5405 |
|
|
2016
Q1 | – | Sell |
-9
| Closed | -$1K | – | 6087 |
|
|
2015
Q4 | $1K | Buy |
+9
| New | +$92 | ﹤0.01% | 4967 |
|
|
2015
Q2 | – | Sell |
-12
| Closed | -$1K | – | 5704 |
|
|
2015
Q1 | $1K | Buy |
+12
| New | +$235 | ﹤0.01% | 4555 |
|
Other funds holding PLX
MCO
SWP
VPM
PFS
OM
Simplex Trading's PLX Position: Q1 2026 in Review
Simplex Trading opened a new position in Protalix BioTherapeutics (PLX) in Q1 2026: 22,671 shares worth $49.2K. The stake represents ﹤0.01% of the portfolio and ranks #5898 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PLX as recently as Q3 2025.
Simplex Trading first reported a position in PLX in Q4 2014 and has held it in 26 quarters since. The position peaked at $197K in Q1 2021. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.
- Simplex Trading held 22,671 shares of Protalix BioTherapeutics worth $49.2K as of Q1 2026.
- Protalix BioTherapeutics was a new Simplex Trading position in Q1 2026.
- Protalix BioTherapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5898 holding.
- Simplex Trading first reported a position in Protalix BioTherapeutics in Q4 2014 and has held it in 26 quarters since.
- Simplex Trading's Protalix BioTherapeutics position peaked at $197K in Q1 2021.
- 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.